
A fourth dose of the Pfizer/BioNTech vaccine lowered rates of COVID-19 among the elderly but the protection against infection appeared short-lived, a large study in Israel has found.
The second booster's protection against infection dwindled after four weeks, Israeli researchers showed in their study published on Tuesday in the New England Journal of Medicine.